Prof. Mark von Itzstein AO
World-renowned biomedical scientist and co-inventor of the anti-influenza drug Relenza; leading international teams targeting glycans in cancers and infectious diseases.
Documented research interests and leadership
- Research areas
- Glycobiology, Rational Drug Design, Viral Sialidases, Infectious Disease Therapeutics
- Academic position
- Founder and Director of the Institute for Glycomics
- Primary university source
- Official directory entry ↗
- Recruitment status
- Not verified. Leadership profile does not imply active vacancies or assistantship availability.
Supervision and contact
Students interested in graduate or doctoral research supervision in Glycobiology, Rational Drug Design, Viral Sialidases are advised to consult formal department application channels.
Important verification note
Facts reflect official university directory records reviewed 2026-10-15. Faculty recruitment and admissions require formal application.
Reviewed 2026-10-15 · Editorial standards · Report an issue